SCHEMBL20208548

SCHEMBL20208548

FC(F)(F)c1cn2cc(-c3ccccc3)ccc2n1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN5A Q14524 1/20 0.68
ALDH1A3 P47895 10/20 0.60
ALDH1A1 P00352 4/20 0.60
ALDH1A2 O94788 1/20 0.60
SLC2A1 P11166 1/20 0.54
EGLN1 Q9GZT9 1/20 0.45
MAP3K5 Q99683 1/20 0.43
MCHR1 Q99705 2/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
KDM4E B2RXH2 1/20 0.41
TP53 P04637 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
CDK5 Q00535 1/20 0.41
KMT2A Q03164 1/20 0.41
CDK5R1 Q15078 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24155459 0.80 SCN5A (0.56) SCN5AALDH1A3ALDH1A1ALDH1A2SLC2A1
SCHEMBL16246668 0.78 ALDH1A3 (0.77) ALDH1A3ALDH1A1ALDH1A2SLC2A1NPC1
SCHEMBL18427020 0.76 SCN5A (0.52) SCN5AALDH1A3ALDH1A1ALDH1A2NPC1
SCHEMBL13325768 0.75 ALDH1A3 (1.00) ALDH1A3ALDH1A1ALDH1A2SLC2A1NPC1
SCHEMBL12056714 0.75 SCN5A (0.54) SCN5AALDH1A3ALDH1A1MAP3K5MCHR1
SCHEMBL161950 0.75 RAB9A (0.49) SCN5AALDH1A1NPC1RAB9AKDM4E
SCHEMBL16872714 0.74 SCN5A (0.47) SCN5AALDH1A3ALDH1A1ALDH1A2SLC2A1
SCHEMBL2118968 0.74 SCN5A (0.53) SCN5AALDH1A1MCHR1NPC1RAB9A
SCHEMBL18080888 0.74 SCN5A (0.53) SCN5AALDH1A1MCHR1NPC1RAB9A
SCHEMBL8812209 0.74 SCN5A (0.53) SCN5AALDH1A3ALDH1A1MAP3K5NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210188839-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PRECISION MEDICINES, INC. 2021-06-24 US disclosed
WO-2018098500-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PRECISION MEDICINES, INC. (US) 2018-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188839-A1 COMPOUNDS AND THEIR METHODS OF USE SCN1A, SCN3A, SCN1B SCN5A 8/4885ALDH1A3 810/4885ALDH1A1 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.